CAN
HRMY icon

Cetera Advisor Networks’s Harmony Biosciences HRMY Stock Holding History

Cetera Advisor Networks’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$203K Buy
+6,041
New +$194K ﹤0.01% 2589

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cetera Advisor Networks's HRMY Position: Q1 2024 in Review

Cetera Advisor Networks opened a new position in Harmony Biosciences (HRMY) in Q1 2024: 6,041 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings.

208 funds tracked by Wall St. Rank hold HRMY as of Q1 2024.

  • Cetera Advisor Networks held 6,041 shares of Harmony Biosciences worth $203K as of Q1 2024.
  • Harmony Biosciences was a new Cetera Advisor Networks position in Q1 2024.
  • Harmony Biosciences made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2589 holding.
  • 208 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.